Comparison Chart Madrigal Pharmaceuticals, Inc.
Stocks
MDGL
US5588681057
Biotechnology & Medical Research
|
Real-time Estimate
Cboe BZX
22:24:25 12/11/2026 +04
|
5-day change | 1st Jan Change | ||
| 426.14 USD | -1.59% |
|
+6.65% | -26.72% |
| 11-06 | HEALTH ROUNDS-New blood test matches gold standard for liver disease diagnosis | RE |
| 11-05 | Madrigal Pharmaceuticals, Inc. Announces Real-World Data Demonstrating Improvements With Rezdiffra | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. | Bio Therapeutic Drugs | -1.57% | +6.65% | -26.72% | -19.33% | +369.75% | 10.06B |  | | |
- Stock Market
- Stocks
- MDGL Stock
- Charts Madrigal Pharmaceuticals, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
